Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2020 Filed Aug 10, 2020 18:08 UTC |
Herman Gerald NVice President, CFO
|
GrantStock Option (Right to Buy) · Derivative | 13,599 | $0.00 Strike: $43.50 | $0.00 |
DisclosureSEC source: 0001179110-20-008824 · edgar.xml · derivative · entry 2 Herman Gerald N · CIK 0001327294 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,599 Underlying: Common Stock · 13,599 shares Expires 2030-08-06 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:08 UTC |
Herman Gerald NVice President, CFO
|
GrantCommon Stock | 12,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008824 · edgar.xml · nonDerivative · entry 1 Herman Gerald N · CIK 0001327294 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,332 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:08 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 58,867 | $0.00 Strike: $47.85 | $0.00 |
DisclosureSEC source: 0001179110-20-008822 · edgar.xml · derivative · entry 8 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,867 Underlying: Common Stock · 58,867 shares Expires 2025-08-06 F3 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:08 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantCommon Stock | 52,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008822 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,120,873 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| June 22, 2020 Filed Jun 22, 2020 21:53 UTC |
Friend Cynthia MDirector
|
SaleCommon Stock | 1,800 | $40.57 | $73,026.00 |
DisclosureSEC source: 0001179110-20-007686 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,857 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.35 to $40.79, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:50 UTC |
Friend Cynthia MDirector
|
SaleCommon Stock | 1,000 | $39.06 | $39,064.00 |
DisclosureSEC source: 0001179110-20-005867 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,657 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.01 to $39.12, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:50 UTC |
Martin Gilles Gerard JeanDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0001179110-20-005866 · edgar.xml · derivative · entry 7 Martin Gilles Gerard Jean · CIK 0001597047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:50 UTC |
Martin Gilles Gerard JeanDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001179110-20-005866 · edgar.xml · derivative · entry 6 Martin Gilles Gerard Jean · CIK 0001597047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:50 UTC |
Martin Gilles Gerard JeanDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $21.74 | $0.00 |
DisclosureSEC source: 0001179110-20-005866 · edgar.xml · derivative · entry 5 Martin Gilles Gerard Jean · CIK 0001597047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:50 UTC |
Martin Gilles Gerard JeanDirector
|
SaleCommon Stock | 30,000 | $38.83 | $1,164,951.00 |
DisclosureSEC source: 0001179110-20-005866 · edgar.xml · nonDerivative · entry 4 Martin Gilles Gerard Jean · CIK 0001597047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,657 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $39.25, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:50 UTC |
Martin Gilles Gerard JeanDirector
|
Exercise / conversionCommon Stock | 10,000 | $24.00 | $240,000.00 |
DisclosureSEC source: 0001179110-20-005866 · edgar.xml · nonDerivative · entry 3 Martin Gilles Gerard Jean · CIK 0001597047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:50 UTC |
Martin Gilles Gerard JeanDirector
|
Exercise / conversionCommon Stock | 10,000 | $19.12 | $191,200.00 |
DisclosureSEC source: 0001179110-20-005866 · edgar.xml · nonDerivative · entry 2 Martin Gilles Gerard Jean · CIK 0001597047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:50 UTC |
Martin Gilles Gerard JeanDirector
|
Exercise / conversionCommon Stock | 10,000 | $21.74 | $217,400.00 |
DisclosureSEC source: 0001179110-20-005866 · edgar.xml · nonDerivative · entry 1 Martin Gilles Gerard Jean · CIK 0001597047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:49 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
PurchaseCommon Stock | 2,500 | $39.11 | $97,775.00 |
DisclosureSEC source: 0001179110-20-005865 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,068,625 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.71 to $39.37, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| March 24, 2020 Filed Mar 25, 2020 22:46 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Exercise / conversionStock option - right to purchase · Derivative | 25,000 | $0.00 Strike: $24.41 | $0.00 |
DisclosureSEC source: 0001179110-20-004125 · edgar.xml · derivative · entry 8 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vest in four approximately equal annual installments on October 4, 2017, 2018, 2019 and 2020. Read SEC document |
| March 24, 2020 Filed Mar 25, 2020 22:46 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Exercise / conversionCommon Stock | 25,000 | $24.41 | $610,225.00 |
DisclosureSEC source: 0001179110-20-004125 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,066,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 16:48 UTC |
Kastner Marc ADirector
|
GrantCommon Stock | 2,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000350 · edgar.xml · nonDerivative · entry 1 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,080 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 6, 2021. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 16:50 UTC |
ROSENTHAL BOBDirector
|
GrantCommon Stock | 2,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000356 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,657 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 6, 2021. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 16:49 UTC |
Requardt Hermann FritzDirector
|
GrantCommon Stock | 2,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000355 · edgar.xml · nonDerivative · entry 1 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,657 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 6, 2021. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 16:49 UTC |
Perkins Adelene QDirector
|
GrantCommon Stock | 2,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000354 · edgar.xml · nonDerivative · entry 1 Perkins Adelene Q · CIK 0001375124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,836 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 6, 2021. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 16:49 UTC |
PACKER RICHARD ADirector
|
GrantCommon Stock | 2,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000353 · edgar.xml · nonDerivative · entry 1 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,764.018 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 6, 2021. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 16:48 UTC |
LINTON WILLIAM ADirector
|
GrantCommon Stock | 2,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000351 · edgar.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,407 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 6, 2021. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 16:49 UTC |
ORNELL JOHN ADirector
|
GrantCommon Stock | 2,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000352 · edgar.xml · nonDerivative · entry 1 ORNELL JOHN A · CIK 0001186875 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,657 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 6, 2021. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 16:48 UTC |
Friend Cynthia MDirector
|
GrantCommon Stock | 2,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000348 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,657 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 6, 2021. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 16:48 UTC |
Martin Gilles Gerard JeanDirector
|
GrantCommon Stock | 2,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000349 · edgar.xml · nonDerivative · entry 1 Martin Gilles Gerard Jean · CIK 0001597047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,657 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 6, 2021. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 18:26 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GiftCommon Stock | 48,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-012882 · edgar.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,041,125 F2 · kind: The reported transaction involved a gift transfer to reporting person as custodian for minor son under Uniform Trust for Minors Act. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 18:26 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantCommon Stock | 12,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-012882 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,090,033 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date commencing December 16, 2020. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 18:27 UTC |
PACKER RICHARD ADirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 6,000 | $0.00 Strike: $12.77 | $0.00 |
DisclosureSEC source: 0001179110-19-012883 · edgar.xml · derivative · entry 7 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2022-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 18:27 UTC |
PACKER RICHARD ADirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 6,000 | $0.00 Strike: $16.09 | $0.00 |
DisclosureSEC source: 0001179110-19-012883 · edgar.xml · derivative · entry 6 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 18:27 UTC |
PACKER RICHARD ADirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 6,000 | $0.00 Strike: $12.48 | $0.00 |
DisclosureSEC source: 0001179110-19-012883 · edgar.xml · derivative · entry 5 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2020-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 18:27 UTC |
PACKER RICHARD ADirector
|
SaleCommon Stock | 18,000 | $49.18 | $885,198.60 |
DisclosureSEC source: 0001179110-19-012883 · edgar.xml · nonDerivative · entry 4 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,292.018 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.78 to $49.38, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 18:27 UTC |
PACKER RICHARD ADirector
|
Exercise / conversionCommon Stock | 6,000 | $12.77 | $76,620.00 |
DisclosureSEC source: 0001179110-19-012883 · edgar.xml · nonDerivative · entry 3 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,292.018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 18:27 UTC |
PACKER RICHARD ADirector
|
Exercise / conversionCommon Stock | 6,000 | $16.09 | $96,540.00 |
DisclosureSEC source: 0001179110-19-012883 · edgar.xml · nonDerivative · entry 2 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,292.018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 18:27 UTC |
PACKER RICHARD ADirector
|
Exercise / conversionCommon Stock | 6,000 | $12.48 | $74,880.00 |
DisclosureSEC source: 0001179110-19-012883 · edgar.xml · nonDerivative · entry 1 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,292.018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 19:12 UTC |
LINTON WILLIAM ADirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 6,000 | $0.00 Strike: $12.48 | $0.00 |
DisclosureSEC source: 0001179110-19-011740 · edgar.xml · derivative · entry 2 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2020-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in three approximately equal annual installments beginning on 01/05/2011. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 19:12 UTC |
LINTON WILLIAM ADirector
|
Exercise / conversionCommon Stock | 6,000 | $12.48 | $74,880.00 |
DisclosureSEC source: 0001179110-19-011740 · edgar.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2019 Filed Nov 7, 2019 19:20 UTC |
Kastner Marc ADirector
|
SaleCommon Stock | 3,203 | $47.39 | $151,775.76 |
DisclosureSEC source: 0001179110-19-011514 · edgar.xml · nonDerivative · entry 1 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,608 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.225 to $47.71, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 04, 2019 Filed Oct 8, 2019 18:20 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 2,291 | $44.27 | $101,422.57 |
DisclosureSEC source: 0001179110-19-010872 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,713 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 20:30 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $19.82 | $0.00 |
DisclosureSEC source: 0001179110-19-010410 · edgar.xml · derivative · entry 7 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2025-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in four approximately equal annual installments on August 7, 2016, 2017, 2018 and 2019. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 20:30 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,144 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0001179110-19-010410 · edgar.xml · derivative · entry 6 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,144 shares Expires 2024-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in four approximately equal annual installments on August 8, 2015, 2016, 2017 and 2018. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 20:30 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,059 | $0.00 Strike: $20.04 | $0.00 |
DisclosureSEC source: 0001179110-19-010410 · edgar.xml · derivative · entry 5 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,059 shares Expires 2023-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in four approximately equal annual installments on August 30, 2014, 2015, 2016 and 2017. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 20:30 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
SaleCommon Stock | 47,203 | $42.87 | $2,023,366.04 |
DisclosureSEC source: 0001179110-19-010410 · edgar.xml · nonDerivative · entry 4 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,004 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.74 to $43.045, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 20:30 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionCommon Stock | 16,000 | $19.82 | $317,120.00 |
DisclosureSEC source: 0001179110-19-010410 · edgar.xml · nonDerivative · entry 3 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 20:30 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionCommon Stock | 16,144 | $20.68 | $333,857.92 |
DisclosureSEC source: 0001179110-19-010410 · edgar.xml · nonDerivative · entry 2 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 20:30 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionCommon Stock | 15,059 | $20.04 | $301,782.36 |
DisclosureSEC source: 0001179110-19-010410 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2019 Filed Sep 12, 2019 17:36 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Exercise / conversionStock option - right to purchase · Derivative | 34,774 | $0.00 Strike: $21.80 | $0.00 |
DisclosureSEC source: 0001179110-19-010279 · edgar.xml · derivative · entry 8 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,774 shares Expires 2020-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in four approximately equal annual installments on August 7, 2016, 2017, 2018 and 2019. Read SEC document |
| September 11, 2019 Filed Sep 12, 2019 17:36 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Exercise / conversionCommon Stock | 34,774 | $21.80 | $758,073.20 |
DisclosureSEC source: 0001179110-19-010279 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,077,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:58 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
SaleCommon Stock | 15,702 | $42.96 | $674,557.92 |
DisclosureSEC source: 0001179110-19-010188 · edgar.xml · nonDerivative · entry 1 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,338 Read SEC document |
| September 05, 2019 Filed Sep 16, 2019 19:58 UTC Amendment |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001179110-19-010357 · edgar.xml · derivative · entry 7 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2026-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The original Form 4 omitted the cash exercise of the three options for a total of 15,702 shares of common stock and therefore also reported an incorrect number of total shares owned in Column 5 of the line item disclosing the sale transaction. F4 · derivative.exercise_date: The option vested partially in two annual installments on October 4, 2017 and 2018 with two installments remaining to vest on October 4, 2019 and 2020. Read SEC document |
| September 05, 2019 Filed Sep 16, 2019 19:58 UTC Amendment |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,984 | $0.00 Strike: $19.82 | $0.00 |
DisclosureSEC source: 0001179110-19-010357 · edgar.xml · derivative · entry 6 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,984 shares Expires 2025-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The original Form 4 omitted the cash exercise of the three options for a total of 15,702 shares of common stock and therefore also reported an incorrect number of total shares owned in Column 5 of the line item disclosing the sale transaction. F3 · derivative.exercise_date: The option vested in four approximately equal annual installments on August 7, 2016, 2017, 2018 and 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.